PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERalpha) degrader compared to PROTAC (without Ab)[1].
Molecular Weight:
1581.85
Formula:
C89H104N12O15
Target:
Estrogen Receptor/ERR,PROTAC-Linker Conjugates for PAC
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
